loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2020_367___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Chunghwa Chemical Synthesis & Biotech

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-Lin TW (1)

    filter

    01 Everolimus (1)

    filter

    01 Taiwan (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Chunghwa Chemical Synthesis & Biote...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag Taiwan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Everolimus

    PDF Supplier PDF
    URL Supplier Web Content
    R0-CEP 2020-367 - Rev 01
    Valid
    Chemical
    2023-05-16
    2918
    CCSB Company Banner

    CPhI Worldwide, Milan

    Attending

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-367 - Rev 01 of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2020-367 - Rev 01 of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw 1

    20

    Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Everolimus, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-367 - Rev 01

    This Chemical Type CEP, issued on May 16, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2918 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY